New hope for Tough-to-Treat colon cancer? trial tests experimental combo
NCT ID NCT07147231
Summary
This early-stage trial is testing a new two-drug combination for people with a hard-to-treat form of advanced colorectal cancer that has stopped responding to standard therapies. The study aims to find a safe dose and see if the combination can help control the cancer's growth. It is for patients whose cancer has specific genetic features and has spread, particularly to the liver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.